| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0755ea316348c8c322671fa495ddd42e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8489d616a897ee0118030351c43e45e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66bfb217a736efd5705774f109da23a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10cb877f955b75034cbbd6c2910567fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94630dc91b4e0a5735a47c17b8edc17d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59195a09dbea88719bbcaec877b5c873
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2ebbe7c79fbb08fa44557ed95c06921 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2005-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_551dfa51274723ad80d3700fb94407c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5569dc6ff962f5ee78dbb8cfd9e5a1eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bfd6dd626eec2949c98ec5cc3af9516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebfe071f0eaf30b86a29f3e510839c57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dab79df29d7e39aa5b1c1b28ad85fe84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a5bd1f4154d56310385d67a0ae1d59e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20c8802bb571bab6135db3a8994ee509 |
| publicationDate |
2006-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006114659-A1 |
| titleOfInvention |
Glycosylation markers for cancer diagnosing and monitoring |
| abstract |
A. method of determining one or more glycosylation markers of cancer comprises obtaining a diseased sample and a control sample, wherein the diseased sample is a sample from a subject diagnosed with cancer and the control sample is a sample from healthy control; releasing a diseased glycan pool of total glycoproteins from the diseased sample and a control glycan pool of total glycoproteins from the control sample without purifying the glycoproteins and without exposing the diseased sample and the control sample to hydrazinolysis; measuring a diseased glycoprofile of the diseased glycan pool and a control glycoprofile of the control glycan pool using chromatography, mass spectrometry or a combination thereof; comparing the diseased glycoprof:ïle and the control glycoprofiles to determine said one or more glycosylation markers of cancer. A method for diagnosing and monitoring cancer in a subject comprising obtaining a sample of body fluid or a body tissue of the subject; releasing a glycan pool of total glycoproteins from the sample without purifying the glycoproteins; measuring a glycoprofile of the glycan pool. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8372647-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009270996-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009044213-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3467503-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9804163-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2909632-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11137405-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113480629-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009168470-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009117106-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113480629-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009013538-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3802624-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009136506-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009013538-A3 |
| priorityDate |
2005-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |